AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40
MYOCARDIAL INJURY IN CHILDREN WITH RESPIRATORY SYNCYTIAL VIRUS-INFECTION
Authors: CHECCHIA PA APPEL HJ CALLAS D KAHN S SMITH FA PAHL E BADEN HP
Citation: Pa. Checchia et al., MYOCARDIAL INJURY IN CHILDREN WITH RESPIRATORY SYNCYTIAL VIRUS-INFECTION, Pediatrics (Evanston), 102(3), 1998, pp. 706-706
ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT
Authors: FAREED J CALLAS D HOPPENSTEADT DA WALENGA JM BICK RL
Citation: J. Fareed et al., ANTITHROMBIN AGENTS AS ANTICOAGULANTS AND ANTITHROMBOTICS - IMPLICATIONS IN DRUG DEVELOPMENT, The Medical clinics of North America, 82(3), 1998, pp. 569
PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN (GAMMA) AND ITS INHIBITION BY GPIIB IIIA/
Authors: ERO M CALLAS D YANG L JESKE W FAREED J
Citation: M. Ero et al., PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN (GAMMA) AND ITS INHIBITION BY GPIIB IIIA/, The FASEB journal, 11(3), 1997, pp. 1825-1825
PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN(GAMMA) AND ITS INHIBITION BY GPIIB IIIA/
Authors: CALLAS D ERO M YANG L JESKE W FAREED J
Citation: D. Callas et al., PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN(GAMMA) AND ITS INHIBITION BY GPIIB IIIA/, Thrombosis and haemostasis, 1997, pp. 2708-2708
MODULATION OF ENDOTHELIUM BY HEPARIN AND RELATED POLYELECTROLYTES
Authors: FAREED J JESKE W CALLAS D HOPPENSTEADT D WALENGA J
Citation: J. Fareed et al., MODULATION OF ENDOTHELIUM BY HEPARIN AND RELATED POLYELECTROLYTES, Clinical and applied thrombosis/hemostasis, 2(3), 1996, pp. 200-208
PHARMACOLOGICAL PROFILING OF RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR
Authors: JESKE W HOPPENSTEADT D CALLAS D KOZA MJ FAREED J
Citation: W. Jeske et al., PHARMACOLOGICAL PROFILING OF RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR, Seminars in thrombosis and hemostasis, 22(2), 1996, pp. 213-219
COMPARATIVE INTRAVENOUS ANTITHROMBOTIC ACTIONS OF HEPARIN AND SITE-DIRECTED THROMBIN INHIBITORS IN A JUGULAR-VEIN CLAMPING MODEL
Authors: HAYES JM JESKE W CALLAS D IQBAL O FAREED J
Citation: Jm. Hayes et al., COMPARATIVE INTRAVENOUS ANTITHROMBOTIC ACTIONS OF HEPARIN AND SITE-DIRECTED THROMBIN INHIBITORS IN A JUGULAR-VEIN CLAMPING MODEL, Thrombosis research, 82(2), 1996, pp. 187-191
MODULATION OF PLATELET-FUNCTION AND VASCULAR SMOOTH-MUSCLE CONTRACTILE ACTIONS BY A NOVEL, SELECTIVE, HIGHLY POTENT 5-HT2 ANTAGONIST (SR46349)
Authors: YANG LH CALLAS D HERBERT JM FAREED J
Citation: Lh. Yang et al., MODULATION OF PLATELET-FUNCTION AND VASCULAR SMOOTH-MUSCLE CONTRACTILE ACTIONS BY A NOVEL, SELECTIVE, HIGHLY POTENT 5-HT2 ANTAGONIST (SR46349), Thrombosis research, 81(5), 1996, pp. 555-567
UTILIZATION OF ECARIN CLOTTING TIME AS A GLOBAL CLOTTING ASSAY FOR THE MONITORING OF THROMBIN INHIBITORS
Authors: HOPPENSTEADT D CALLAS D BERMES E FAREED J
Citation: D. Hoppensteadt et al., UTILIZATION OF ECARIN CLOTTING TIME AS A GLOBAL CLOTTING ASSAY FOR THE MONITORING OF THROMBIN INHIBITORS, Clinical chemistry, 42(6), 1996, pp. 15-15
ANTITHROMBIN UNIT POTENCY EVALUATION OF THROMBIN INHIBITORS UTILIZINGAN AMIDOLYTIC METHOD
Authors: CALLAS D HOPPENSTEADT D BERMES E FAREED J
Citation: D. Callas et al., ANTITHROMBIN UNIT POTENCY EVALUATION OF THROMBIN INHIBITORS UTILIZINGAN AMIDOLYTIC METHOD, Clinical chemistry, 42(6), 1996, pp. 402-402
PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN-(GAMMA) AND ITS INHIBITION BY GPIIB IIIA/
Authors: CALLAS D YANG L HOPPENSTEADT D JESKE W FAREED J
Citation: D. Callas et al., PLATELET ACTIVATION BY A NON-COAGULANT FORM OF THROMBIN-(GAMMA) AND ITS INHIBITION BY GPIIB IIIA/, Blood, 88(10), 1996, pp. 2914-2914
COMPARATIVE PHARMACOLOGY OF SITE-DIRECTED ANTITHROMBIN AGENTS - IMPLICATION IN DRUG DEVELOPMENT
Authors: CALLAS D FAREED J
Citation: D. Callas et J. Fareed, COMPARATIVE PHARMACOLOGY OF SITE-DIRECTED ANTITHROMBIN AGENTS - IMPLICATION IN DRUG DEVELOPMENT, Thrombosis and haemostasis, 74(1), 1995, pp. 473-481
ANTITHROMBIN-III AFFINITY DEPENDENCE ON THE ANTICOAGULANT, ANTIPROTEASE AND TISSUE FACTOR PATHWAY INHIBITOR MODULATORY ACTIONS OF HEPARIN
Authors: JESKE W CALLAS D LORMEAU JC IQBAL O HOPPENSTEADT D FAREED J
Citation: W. Jeske et al., ANTITHROMBIN-III AFFINITY DEPENDENCE ON THE ANTICOAGULANT, ANTIPROTEASE AND TISSUE FACTOR PATHWAY INHIBITOR MODULATORY ACTIONS OF HEPARIN, Thrombosis and haemostasis, 73(6), 1995, pp. 935-935
COMPARATIVE-STUDIES ON THE ANTICOAGULANT AND PROTEASE GENERATION INHIBITORY ACTIONS OF NEWLY DEVELOPED SITE-DIRECTED THROMBIN INHIBITORY DRUGS - EFEGATRAN(R), ARGATROBAN(R), HIRULOG(R) AND HIRUDIN
Authors: CALLAS D HOPPENSTEADT D MALINOWSKA K WALENGA JM FAREED J
Citation: D. Callas et al., COMPARATIVE-STUDIES ON THE ANTICOAGULANT AND PROTEASE GENERATION INHIBITORY ACTIONS OF NEWLY DEVELOPED SITE-DIRECTED THROMBIN INHIBITORY DRUGS - EFEGATRAN(R), ARGATROBAN(R), HIRULOG(R) AND HIRUDIN, Thrombosis and haemostasis, 73(6), 1995, pp. 1307-1307
ANTITHROMBOTIC AND VASOMODULATORY ACTION OF A SELECTIVE ANTI-ADP AGENT, CLOPIDOGREL HYL(2-CHLOROPHENYL)-5-(4,5,6,7-TETRAHYDROTHIOEENO) (3,2-C)PYRIDINYL) ACETATE HYDROGEN SULFATE]
Authors: YANG LH CALLAS D IQBAL O
Citation: Lh. Yang et al., ANTITHROMBOTIC AND VASOMODULATORY ACTION OF A SELECTIVE ANTI-ADP AGENT, CLOPIDOGREL HYL(2-CHLOROPHENYL)-5-(4,5,6,7-TETRAHYDROTHIOEENO) (3,2-C)PYRIDINYL) ACETATE HYDROGEN SULFATE], Thrombosis and haemostasis, 73(6), 1995, pp. 1316-1316
RECOMBINANT TISSUE FACTOR PATHWAY INHIBITORS AS ANTITHROMBOTIC AND ANTICOAGULANT AGENTS
Authors: FAREED J HOPPENSTEADT D JESKE W CALLAS D IQBAL O FU KD
Citation: J. Fareed et al., RECOMBINANT TISSUE FACTOR PATHWAY INHIBITORS AS ANTITHROMBOTIC AND ANTICOAGULANT AGENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1319-1319
COMPARISON OF THE ANTICOAGULANT ACTIVITIES OF THROMBIN INHIBITORS AS ASSESSED BY THROMBOELASTOGRAPHIC ANALYSIS
Authors: CALLAS D IQBAL O FAREED J
Citation: D. Callas et al., COMPARISON OF THE ANTICOAGULANT ACTIVITIES OF THROMBIN INHIBITORS AS ASSESSED BY THROMBOELASTOGRAPHIC ANALYSIS, Seminars in thrombosis and hemostasis, 21, 1995, pp. 76-79
ANTITHROMBIN-III AFFINITY DEPENDENCE ON THE ANTICOAGULANT, ANTIPROTEASE, AND TISSUE FACTOR PATHWAY INHIBITOR ACTIONS OF HEPARINS
Authors: JESKE W LORMEAU JC CALLAS D IQBAL O HOPPENSTEADT D FAREED J
Citation: W. Jeske et al., ANTITHROMBIN-III AFFINITY DEPENDENCE ON THE ANTICOAGULANT, ANTIPROTEASE, AND TISSUE FACTOR PATHWAY INHIBITOR ACTIONS OF HEPARINS, Seminars in thrombosis and hemostasis, 21(2), 1995, pp. 193-200
PLASMA MEDIATED ENHANCEMENT OF THE AMIDOLYTIC ACTION ACTIVATED PROTEIN-C
Authors: CALLAS D HOPPENSTEADT D DROHAN WN FAREED J BERMES EW
Citation: D. Callas et al., PLASMA MEDIATED ENHANCEMENT OF THE AMIDOLYTIC ACTION ACTIVATED PROTEIN-C, Clinical chemistry, 41(6), 1995, pp. 150-150
SELECTION OF OPTIMAL ASSAY CONDITIONS AND REAGENTS FOR A RAPID AUTOMATED SCREENING OF THE ACTIVATED PROTEIN-C RESISTANCE FOR BATCH SCREENING
Authors: CALLAS D JESKE W HOPPENSTEADT D CALIXTE C DROHAN W FAREED J BERMES EW
Citation: D. Callas et al., SELECTION OF OPTIMAL ASSAY CONDITIONS AND REAGENTS FOR A RAPID AUTOMATED SCREENING OF THE ACTIVATED PROTEIN-C RESISTANCE FOR BATCH SCREENING, Clinical chemistry, 41(6), 1995, pp. 200-200
INHIBITION OF PROTEASE GENERATION BY ACTIVATED PROTEIN-C IN THE ABSENCE AND PRESENCE OF TISSUE FACTOR PATHWAY INHIBITOR
Authors: KAISER B CALLAS D HOPPENSTEADT D FAREED J
Citation: B. Kaiser et al., INHIBITION OF PROTEASE GENERATION BY ACTIVATED PROTEIN-C IN THE ABSENCE AND PRESENCE OF TISSUE FACTOR PATHWAY INHIBITOR, Blood, 86(10), 1995, pp. 3490-3490
SELECTION OF OPTIMAL ASSAY CONDITIONS AND REAGENTS FOR A RAPID AUTOMATED SCREENING OF THE ACTIVATED PROTEIN-C RESISTANCE FOR BATCH SCREENING
Authors: BICK R CALLAS D JESKE W HOPPENSTEADT D DROHAN W FAREED J BERMES E
Citation: R. Bick et al., SELECTION OF OPTIMAL ASSAY CONDITIONS AND REAGENTS FOR A RAPID AUTOMATED SCREENING OF THE ACTIVATED PROTEIN-C RESISTANCE FOR BATCH SCREENING, Blood, 86(10), 1995, pp. 3644-3644
MODULATION OF PLATELET-FUNCTION AND VASCULAR SMOOTH-MUSCLE CONTRACTILE ACTIONS BY TWO NEW 5HT2 ANTAGONIST (SR 46615A AND SR 46349B)
Authors: YANG L CALLAS D KINDEL G HERBERT JM FAREED J
Citation: L. Yang et al., MODULATION OF PLATELET-FUNCTION AND VASCULAR SMOOTH-MUSCLE CONTRACTILE ACTIONS BY TWO NEW 5HT2 ANTAGONIST (SR 46615A AND SR 46349B), The FASEB journal, 8(5), 1994, pp. 10000604-10000604
COMPARATIVE ANTITHROMBOTIC EFFECTS OF 4 THROMBIN INHIBITORS IN A MODIFIED WESSLER MODEL WITH TISSUE FACTOR INITIATING THE THROMBOGENIC EVENT
Authors: CALLAS D IQBAL O FAREED J
Citation: D. Callas et al., COMPARATIVE ANTITHROMBOTIC EFFECTS OF 4 THROMBIN INHIBITORS IN A MODIFIED WESSLER MODEL WITH TISSUE FACTOR INITIATING THE THROMBOGENIC EVENT, The FASEB journal, 8(5), 1994, pp. 10000641-10000641
HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - IMPLICATIONS IN THE OVERALL ANTICOAGULANT RESPONSES
Authors: FASANELLA T MALINOWSKA K JESKE W CALLAS D HOPPENSTEADT D FAREED J
Citation: T. Fasanella et al., HEPARIN-RELEASABLE TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - IMPLICATIONS IN THE OVERALL ANTICOAGULANT RESPONSES, The FASEB journal, 8(5), 1994, pp. 10000641-10000641
Risultati: 1-25 | 26-40